_id
69130afeccc777a4e85d7c59
Ticker
KNSA
Name
Kiniksa Pharmaceuticals Ltd
Exchange
NASDAQ
Address
23 Old Bond Street, London, United Kingdom, WIS 4PZ
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.kiniksa.com
Description
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-387, an investigational, that is in Phase 2/3 clinical trial for human immunoglobulin G2 monoclonal antibody that binds human interleukin-1 receptor 1, inhibiting IL-1a, IL-1ß-mediated signaling for the treatment of advance recurrent pericarditis by providing the added convenience of monthly subcutaneous dosing with a liquid formulation. Its preclinical products include KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.
Last Close
41.55
Volume
108179
Current Price
41.41
Change
-0.3369434416365838
Last Updated
2025-12-01T09:58:27.491Z
Image
data:image/webp;base64,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
Ipo Date
2018-05-24T00:00:00.000Z
Market Cap
3222835712
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9851666666666667
Sentiment Sources
6
Rating
4.6667
Target Price
54
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
180855000
Cost Of Revenue
83591000
Gross Profit
97264000
Operating Expenses
73243000
Operating Income
24021000
Interest Expense
-
Pretax Income
27157000
Net Income
18435000
Eps
0.23626324967764517
Dividends Per Share
-
Shares Outstanding
45161019
Income Tax Expense
8722000
EBITDA
27541000
Operating Margin
13.281910923115204
Total Other Income Expense Net
3136000
Cash
174858000
Short Term Investments
177244000
Receivables
51742000
Inventories
41396000
Total Current Assets
475530000
Property Plant Equipment
11728000
Total Assets
712333000
Payables
6150000
Short Term Debt
2696000
Long Term Debt
-
Total Liabilities
176950000
Equity
535383000
Depreciation
384000
Change In Working Capital
-1017000
Cash From Operations
33677000
Capital Expenditures
671000
Cash From Investing
-62755000
Cash From Financing
11899000
Net Change In Cash
-17179000
PE
94.4889
PB
6.035143797430997
ROE
3.443329354873054
ROA
2.5879750060715985
FCF
33006000
Fcf Percent
0.1824997926515717
Piotroski FScore
4
Health Score
65
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
7.3
Garp Investing Score
5.5
Growth Investing Score
4
Momentum Investing Score
3.5
Net Net Investing Score
4
Quality Investing Score
7.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
180855000
Quarters > 0 > income Statement > cost Of Revenue
83591000
Quarters > 0 > income Statement > gross Profit
97264000
Quarters > 0 > income Statement > operating Expenses
73243000
Quarters > 0 > income Statement > operating Income
24021000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
27157000
Quarters > 0 > income Statement > net Income
18435000
Quarters > 0 > income Statement > eps
0.23626324967764517
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
78027370
Quarters > 0 > income Statement > income Tax Expense
8722000
Quarters > 0 > income Statement > EBITDA
27541000
Quarters > 0 > income Statement > operating Margin
13.281910923115204
Quarters > 0 > income Statement > total Other Income Expense Net
3136000
Quarters > 0 > balance Sheet > cash
174858000
Quarters > 0 > balance Sheet > short Term Investments
177244000
Quarters > 0 > balance Sheet > receivables
51742000
Quarters > 0 > balance Sheet > inventories
41396000
Quarters > 0 > balance Sheet > total Current Assets
475530000
Quarters > 0 > balance Sheet > property Plant Equipment
11728000
Quarters > 0 > balance Sheet > total Assets
712333000
Quarters > 0 > balance Sheet > payables
6150000
Quarters > 0 > balance Sheet > short Term Debt
2696000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
176950000
Quarters > 0 > balance Sheet > equity
535383000
Quarters > 0 > cash Flow > net Income
18435000
Quarters > 0 > cash Flow > depreciation
384000
Quarters > 0 > cash Flow > change In Working Capital
-1017000
Quarters > 0 > cash Flow > cash From Operations
33677000
Quarters > 0 > cash Flow > capital Expenditures
671000
Quarters > 0 > cash Flow > cash From Investing
-62755000
Quarters > 0 > cash Flow > cash From Financing
11899000
Quarters > 0 > cash Flow > net Change In Cash
-17179000
Quarters > 0 > ratios > PE
0.23626324967764517
Quarters > 0 > ratios > PB
6.035143797430997
Quarters > 0 > ratios > ROE
3.443329354873054
Quarters > 0 > ratios > ROA
2.5879750060715985
Quarters > 0 > ratios > FCF
33006000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.1824997926515717
Quarters > 0 > health Score
65
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
156797000
Quarters > 1 > income Statement > cost Of Revenue
71021000
Quarters > 1 > income Statement > gross Profit
85763000
Quarters > 1 > income Statement > operating Expenses
65616000
Quarters > 1 > income Statement > operating Income
20160000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
22877000
Quarters > 1 > income Statement > net Income
17832000
Quarters > 1 > income Statement > eps
0.2287855071719997
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
77942000
Quarters > 1 > income Statement > income Tax Expense
5045000
Quarters > 1 > income Statement > EBITDA
20518000
Quarters > 1 > income Statement > operating Margin
12.857388853103057
Quarters > 1 > income Statement > total Other Income Expense Net
2717000
Quarters > 1 > balance Sheet > cash
192037000
Quarters > 1 > balance Sheet > short Term Investments
115745000
Quarters > 1 > balance Sheet > receivables
31910000
Quarters > 1 > balance Sheet > inventories
48181000
Quarters > 1 > balance Sheet > total Current Assets
420311000
Quarters > 1 > balance Sheet > property Plant Equipment
11380000
Quarters > 1 > balance Sheet > total Assets
661150000
Quarters > 1 > balance Sheet > payables
8956000
Quarters > 1 > balance Sheet > short Term Debt
2522000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
166143000
Quarters > 1 > balance Sheet > equity
495007000
Quarters > 1 > cash Flow > net Income
17832000
Quarters > 1 > cash Flow > depreciation
358000
Quarters > 1 > cash Flow > change In Working Capital
-1666000
Quarters > 1 > cash Flow > cash From Operations
28090000
Quarters > 1 > cash Flow > capital Expenditures
165000
Quarters > 1 > cash Flow > cash From Investing
-3883000
Quarters > 1 > cash Flow > cash From Financing
10698000
Quarters > 1 > cash Flow > net Change In Cash
34905000
Quarters > 1 > ratios > PE
0.2287855071719997
Quarters > 1 > ratios > PB
6.520267834596278
Quarters > 1 > ratios > ROE
3.6023732997715183
Quarters > 1 > ratios > ROA
2.6971186568857295
Quarters > 1 > ratios > FCF
27925000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.17809651970382087
Quarters > 1 > health Score
65
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
137785000
Quarters > 2 > income Statement > cost Of Revenue
61658000
Quarters > 2 > income Statement > gross Profit
76127000
Quarters > 2 > income Statement > operating Expenses
62855000
Quarters > 2 > income Statement > operating Income
13272000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
15565000
Quarters > 2 > income Statement > net Income
8539000
Quarters > 2 > income Statement > eps
0.11214040067467047
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
76145617
Quarters > 2 > income Statement > income Tax Expense
7026000
Quarters > 2 > income Statement > EBITDA
13617000
Quarters > 2 > income Statement > operating Margin
9.632398301701926
Quarters > 2 > income Statement > total Other Income Expense Net
2293000
Quarters > 2 > balance Sheet > cash
157132000
Quarters > 2 > balance Sheet > short Term Investments
111208000
Quarters > 2 > balance Sheet > receivables
40065000
Quarters > 2 > balance Sheet > inventories
22069000
Quarters > 2 > balance Sheet > total Current Assets
355907000
Quarters > 2 > balance Sheet > property Plant Equipment
11059000
Quarters > 2 > balance Sheet > total Assets
599326000
Quarters > 2 > balance Sheet > payables
1982000
Quarters > 2 > balance Sheet > short Term Debt
2292000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
141837000
Quarters > 2 > balance Sheet > equity
457489000
Quarters > 2 > cash Flow > net Income
8539000
Quarters > 2 > cash Flow > depreciation
345000
Quarters > 2 > cash Flow > change In Working Capital
1599000
Quarters > 2 > cash Flow > cash From Operations
22324000
Quarters > 2 > cash Flow > capital Expenditures
99000
Quarters > 2 > cash Flow > cash From Investing
-51541000
Quarters > 2 > cash Flow > cash From Financing
2768000
Quarters > 2 > cash Flow > net Change In Cash
-26449000
Quarters > 2 > ratios > PE
0.11214040067467047
Quarters > 2 > ratios > PB
6.89238429769896
Quarters > 2 > ratios > ROE
1.8664929648581712
Quarters > 2 > ratios > ROA
1.4247671551042336
Quarters > 2 > ratios > FCF
22225000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.1613020285226984
Quarters > 2 > health Score
60
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
122536000
Quarters > 3 > income Statement > cost Of Revenue
66173000
Quarters > 3 > income Statement > gross Profit
56363000
Quarters > 3 > income Statement > operating Expenses
75662000
Quarters > 3 > income Statement > operating Income
-19299000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-16979000
Quarters > 3 > income Statement > net Income
-8888000
Quarters > 3 > income Statement > eps
-0.12289992947911338
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
72319000
Quarters > 3 > income Statement > income Tax Expense
-8090999
Quarters > 3 > income Statement > EBITDA
-16579000
Quarters > 3 > income Statement > operating Margin
-15.749657243585558
Quarters > 3 > income Statement > total Other Income Expense Net
2320000
Quarters > 3 > balance Sheet > cash
183581000
Quarters > 3 > balance Sheet > short Term Investments
60046000
Quarters > 3 > balance Sheet > receivables
41724000
Quarters > 3 > balance Sheet > inventories
26364000
Quarters > 3 > balance Sheet > total Current Assets
331799000
Quarters > 3 > balance Sheet > property Plant Equipment
11038000
Quarters > 3 > balance Sheet > total Assets
580553000
Quarters > 3 > balance Sheet > payables
2039000
Quarters > 3 > balance Sheet > short Term Debt
1993000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
142117000
Quarters > 3 > balance Sheet > equity
438436000
Quarters > 3 > cash Flow > net Income
-8888000
Quarters > 3 > cash Flow > depreciation
400000
Quarters > 3 > cash Flow > change In Working Capital
20537000
Quarters > 3 > cash Flow > cash From Operations
18770000
Quarters > 3 > cash Flow > capital Expenditures
193000
Quarters > 3 > cash Flow > cash From Investing
65293000
Quarters > 3 > cash Flow > cash From Financing
2142000
Quarters > 3 > cash Flow > net Change In Cash
86205000
Quarters > 3 > ratios > PE
-0.12289992947911338
Quarters > 3 > ratios > PB
6.83048333166072
Quarters > 3 > ratios > ROE
-2.027205795144559
Quarters > 3 > ratios > ROA
-1.5309541075491815
Quarters > 3 > ratios > FCF
18577000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.1516044264542665
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
423239000
Annuals > 0 > income Statement > cost Of Revenue
60910000
Annuals > 0 > income Statement > gross Profit
362329000
Annuals > 0 > income Statement > operating Expenses
407945000
Annuals > 0 > income Statement > operating Income
-45616000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-36152000
Annuals > 0 > income Statement > net Income
-43193000
Annuals > 0 > income Statement > eps
-0.604740703405018
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
71424000
Annuals > 0 > income Statement > income Tax Expense
7041000
Annuals > 0 > income Statement > EBITDA
-43921000
Annuals > 0 > income Statement > operating Margin
-10.777834745852816
Annuals > 0 > income Statement > total Other Income Expense Net
9464000
Annuals > 0 > balance Sheet > cash
183581000
Annuals > 0 > balance Sheet > short Term Investments
60046000
Annuals > 0 > balance Sheet > receivables
41724000
Annuals > 0 > balance Sheet > inventories
26364000
Annuals > 0 > balance Sheet > total Current Assets
331799000
Annuals > 0 > balance Sheet > property Plant Equipment
11038000
Annuals > 0 > balance Sheet > total Assets
580553000
Annuals > 0 > balance Sheet > payables
2039000
Annuals > 0 > balance Sheet > short Term Debt
1993000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
142117000
Annuals > 0 > balance Sheet > equity
438436000
Annuals > 0 > cash Flow > net Income
-43193000
Annuals > 0 > cash Flow > depreciation
1695000
Annuals > 0 > cash Flow > change In Working Capital
24809000
Annuals > 0 > cash Flow > cash From Operations
25689000
Annuals > 0 > cash Flow > capital Expenditures
277000
Annuals > 0 > cash Flow > cash From Investing
37672000
Annuals > 0 > cash Flow > cash From Financing
12266000
Annuals > 0 > cash Flow > net Change In Cash
75627000
Annuals > 0 > ratios > PE
-0.604740703405018
Annuals > 0 > ratios > PB
6.926777180705965
Annuals > 0 > ratios > ROE
-9.851608900728955
Annuals > 0 > ratios > ROA
-7.439975333862714
Annuals > 0 > ratios > FCF
25412000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.06004172583339437
Annuals > 0 > health Score
32
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
270259000
Annuals > 1 > income Statement > cost Of Revenue
56524000
Annuals > 1 > income Statement > gross Profit
213735000
Annuals > 1 > income Statement > operating Expenses
238931000
Annuals > 1 > income Statement > operating Income
-25196000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-16652000
Annuals > 1 > income Statement > net Income
14084000
Annuals > 1 > income Statement > eps
0.1958207617141213
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
71922915
Annuals > 1 > income Statement > income Tax Expense
-30736000
Annuals > 1 > income Statement > EBITDA
-22855000
Annuals > 1 > income Statement > operating Margin
-9.322908765295512
Annuals > 1 > income Statement > total Other Income Expense Net
8544000
Annuals > 1 > balance Sheet > cash
107954000
Annuals > 1 > balance Sheet > short Term Investments
98417000
Annuals > 1 > balance Sheet > receivables
21266000
Annuals > 1 > balance Sheet > inventories
31122000
Annuals > 1 > balance Sheet > total Current Assets
276297000
Annuals > 1 > balance Sheet > property Plant Equipment
12665000
Annuals > 1 > balance Sheet > total Assets
526322000
Annuals > 1 > balance Sheet > payables
8246000
Annuals > 1 > balance Sheet > short Term Debt
2253000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
87483000
Annuals > 1 > balance Sheet > equity
438839000
Annuals > 1 > cash Flow > net Income
14084000
Annuals > 1 > cash Flow > depreciation
2341000
Annuals > 1 > cash Flow > change In Working Capital
1350000
Annuals > 1 > cash Flow > cash From Operations
13301000
Annuals > 1 > cash Flow > capital Expenditures
130000
Annuals > 1 > cash Flow > cash From Investing
-29557000
Annuals > 1 > cash Flow > cash From Financing
1495000
Annuals > 1 > cash Flow > net Change In Cash
-14761000
Annuals > 1 > ratios > PE
0.1958207617141213
Annuals > 1 > ratios > PB
6.968756983312787
Annuals > 1 > ratios > ROE
3.20937747100873
Annuals > 1 > ratios > ROA
2.675928424044596
Annuals > 1 > ratios > FCF
13171000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.04873473223833434
Annuals > 1 > health Score
50
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
220180000
Annuals > 2 > income Statement > cost Of Revenue
22895000
Annuals > 2 > income Statement > gross Profit
197285000
Annuals > 2 > income Statement > operating Expenses
187512000
Annuals > 2 > income Statement > operating Income
9773000
Annuals > 2 > income Statement > interest Expense
1253000
Annuals > 2 > income Statement > pretax Income
11026000
Annuals > 2 > income Statement > net Income
183363000
Annuals > 2 > income Statement > eps
2.603799457215529
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
70421322
Annuals > 2 > income Statement > income Tax Expense
-172337000
Annuals > 2 > income Statement > EBITDA
12175000
Annuals > 2 > income Statement > operating Margin
4.438641111817604
Annuals > 2 > income Statement > total Other Income Expense Net
1253000
Annuals > 2 > balance Sheet > cash
122715000
Annuals > 2 > balance Sheet > short Term Investments
67893000
Annuals > 2 > balance Sheet > receivables
20316000
Annuals > 2 > balance Sheet > inventories
21599000
Annuals > 2 > balance Sheet > total Current Assets
243060000
Annuals > 2 > balance Sheet > property Plant Equipment
7043000
Annuals > 2 > balance Sheet > total Assets
459672000
Annuals > 2 > balance Sheet > payables
7899000
Annuals > 2 > balance Sheet > short Term Debt
3301000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
63523000
Annuals > 2 > balance Sheet > equity
396149000
Annuals > 2 > cash Flow > net Income
183363000
Annuals > 2 > cash Flow > depreciation
2402000
Annuals > 2 > cash Flow > change In Working Capital
-22575000
Annuals > 2 > cash Flow > cash From Operations
5807000
Annuals > 2 > cash Flow > capital Expenditures
105000
Annuals > 2 > cash Flow > cash From Investing
-8078000
Annuals > 2 > cash Flow > cash From Financing
2516000
Annuals > 2 > cash Flow > net Change In Cash
245000
Annuals > 2 > ratios > PE
2.603799457215529
Annuals > 2 > ratios > PB
7.5585565316080565
Annuals > 2 > ratios > ROE
46.286372046881354
Annuals > 2 > ratios > ROA
39.88996501853496
Annuals > 2 > ratios > FCF
5702000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.025896993369061677
Annuals > 2 > health Score
69
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
38544000
Annuals > 3 > income Statement > cost Of Revenue
9100000
Annuals > 3 > income Statement > gross Profit
29444000
Annuals > 3 > income Statement > operating Expenses
186080000
Annuals > 3 > income Statement > operating Income
-156636000
Annuals > 3 > income Statement > interest Expense
2452000
Annuals > 3 > income Statement > pretax Income
-156539000
Annuals > 3 > income Statement > net Income
-157924000
Annuals > 3 > income Statement > eps
-2.3028776054179247
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
68576810
Annuals > 3 > income Statement > income Tax Expense
1385000
Annuals > 3 > income Statement > EBITDA
-154281000
Annuals > 3 > income Statement > operating Margin
-406.3823163138232
Annuals > 3 > income Statement > total Other Income Expense Net
97000
Annuals > 3 > balance Sheet > cash
122470000
Annuals > 3 > balance Sheet > short Term Investments
59731000
Annuals > 3 > balance Sheet > receivables
3985000
Annuals > 3 > balance Sheet > inventories
3675000
Annuals > 3 > balance Sheet > total Current Assets
196446000
Annuals > 3 > balance Sheet > property Plant Equipment
8384000
Annuals > 3 > balance Sheet > total Assets
232800000
Annuals > 3 > balance Sheet > payables
1868000
Annuals > 3 > balance Sheet > short Term Debt
3381000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
47763000
Annuals > 3 > balance Sheet > equity
185037000
Annuals > 3 > cash Flow > net Income
-157924000
Annuals > 3 > cash Flow > depreciation
2355000
Annuals > 3 > cash Flow > change In Working Capital
689000
Annuals > 3 > cash Flow > cash From Operations
-126298000
Annuals > 3 > cash Flow > capital Expenditures
20415000
Annuals > 3 > cash Flow > cash From Investing
128635000
Annuals > 3 > cash Flow > cash From Financing
5885000
Annuals > 3 > cash Flow > net Change In Cash
8222000
Annuals > 3 > ratios > PE
-2.3028776054179247
Annuals > 3 > ratios > PB
15.758394057404736
Annuals > 3 > ratios > ROE
-85.34725487334966
Annuals > 3 > ratios > ROA
-67.83676975945018
Annuals > 3 > ratios > FCF
-146713000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.8063771274387714
Annuals > 3 > health Score
26
Valuation > metrics > PE
94.4889
Valuation > metrics > PB
6.035143797430997
Valuation > final Score
1
Valuation > verdict
189.6% Overvalued
Profitability > metrics > ROE
3.443329354873054
Profitability > metrics > ROA
3.8767270203772632
Profitability > metrics > Net Margin
0.10193248735174587
Profitability > final Score
34
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.33051105470289494
Risk > metrics > Interest Coverage
62.5546875
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
53.75650011304545
Liquidity > metrics > Quick Ratio
49.07687090210265
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
20
Prev Profitabilities > 0
37
Prev Profitabilities > 1
20
Prev Profitabilities > 2
0
Prev Risks > 0
94
Prev Risks > 1
87
Prev Risks > 2
-133
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:54:24.673Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-04
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.23
Earnings History > 0 > eps Estimate
0.3139
Earnings History > 0 > eps Difference
-0.0839
Earnings History > 0 > surprise Percent
-26.7283
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.23
Earnings History > 1 > eps Estimate
0.19
Earnings History > 1 > eps Difference
0.04
Earnings History > 1 > surprise Percent
21.0526
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.11
Earnings History > 2 > eps Estimate
0.2833
Earnings History > 2 > eps Difference
-0.1733
Earnings History > 2 > surprise Percent
-61.1719
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.12
Earnings History > 3 > eps Estimate
0.02
Earnings History > 3 > eps Difference
-0.14
Earnings History > 3 > surprise Percent
-700
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-29
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.18
Earnings History > 4 > eps Estimate
0.01
Earnings History > 4 > eps Difference
-0.19
Earnings History > 4 > surprise Percent
-1900
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-07-23
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.06
Earnings History > 5 > eps Estimate
-0.07
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
14.2857
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-04-23
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.25
Earnings History > 6 > eps Estimate
-0.16
Earnings History > 6 > eps Difference
-0.09
Earnings History > 6 > surprise Percent
-56.25
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.35
Earnings History > 7 > eps Estimate
-0.14
Earnings History > 7 > eps Difference
0.49
Earnings History > 7 > surprise Percent
350
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-10-31
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.2
Earnings History > 8 > eps Estimate
-0.17
Earnings History > 8 > eps Difference
-0.03
Earnings History > 8 > surprise Percent
-17.6471
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-07-25
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.21
Earnings History > 9 > eps Estimate
-0.17
Earnings History > 9 > eps Difference
0.38
Earnings History > 9 > surprise Percent
223.5294
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-02
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.18
Earnings History > 10 > eps Estimate
-0.21
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
14.2857
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.06
Earnings History > 11 > eps Estimate
-0.23
Earnings History > 11 > eps Difference
0.29
Earnings History > 11 > surprise Percent
126.087
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-01
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
3.18
Earnings History > 12 > eps Estimate
0.78
Earnings History > 12 > eps Difference
2.4
Earnings History > 12 > surprise Percent
307.6923
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-03
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.29
Earnings History > 13 > eps Estimate
-0.44
Earnings History > 13 > eps Difference
0.15
Earnings History > 13 > surprise Percent
34.0909
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-03
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.36
Earnings History > 14 > eps Estimate
-0.41
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
12.1951
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-22
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.53
Earnings History > 15 > eps Estimate
-0.42
Earnings History > 15 > eps Difference
-0.11
Earnings History > 15 > surprise Percent
-26.1905
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-01
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.44
Earnings History > 16 > eps Estimate
-0.65
Earnings History > 16 > eps Difference
0.21
Earnings History > 16 > surprise Percent
32.3077
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-03
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.61
Earnings History > 17 > eps Estimate
-0.79
Earnings History > 17 > eps Difference
0.18
Earnings History > 17 > surprise Percent
22.7848
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-04
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.72
Earnings History > 18 > eps Estimate
-0.72
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-23
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.79
Earnings History > 19 > eps Estimate
-0.62
Earnings History > 19 > eps Difference
-0.17
Earnings History > 19 > surprise Percent
-27.4194
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.66
Earnings History > 20 > eps Estimate
-0.6
Earnings History > 20 > eps Difference
-0.06
Earnings History > 20 > surprise Percent
-10
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-07-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.65
Earnings History > 21 > eps Estimate
-0.63
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-3.1746
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-04-28
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.48
Earnings History > 22 > eps Estimate
-0.63
Earnings History > 22 > eps Difference
0.15
Earnings History > 22 > surprise Percent
23.8095
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-02-26
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.58
Earnings History > 23 > eps Estimate
-0.62
Earnings History > 23 > eps Difference
0.04
Earnings History > 23 > surprise Percent
6.4516
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-10-28
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.49
Earnings History > 24 > eps Estimate
-0.72
Earnings History > 24 > eps Difference
0.23
Earnings History > 24 > surprise Percent
31.9444
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-12
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.68
Earnings History > 25 > eps Estimate
-0.72
Earnings History > 25 > eps Difference
0.04
Earnings History > 25 > surprise Percent
5.5556
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-02
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.27
Earnings History > 26 > eps Estimate
-0.8
Earnings History > 26 > eps Difference
-0.47
Earnings History > 26 > surprise Percent
-58.75
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-07
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.88
Earnings History > 27 > eps Estimate
-0.75
Earnings History > 27 > eps Difference
-0.13
Earnings History > 27 > surprise Percent
-17.3333
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-01
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.51
Earnings History > 28 > eps Estimate
-0.54
Earnings History > 28 > eps Difference
0.03
Earnings History > 28 > surprise Percent
5.5556
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-06
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.97
Earnings History > 29 > eps Estimate
-0.44
Earnings History > 29 > eps Difference
-0.53
Earnings History > 29 > surprise Percent
-120.4545
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-24
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.1
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-07
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
0.02
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0.02
Earnings History > 31 > surprise Percent
-
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-387, an investigational, that is in Phase 2/3 clinical trial for human immunoglobulin G2 monoclonal antibody that binds human interleukin-1 receptor 1, inhibiting IL-1a, IL-1ß-mediated signaling for the treatment of advance recurrent pericarditis by providing the added convenience of monthly subcutaneous dosing with a liquid formulation. Its preclinical products include KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow KNSA stock reacts to global recession fears - Breakout Watch & Long-Term Growth Plans - Улправда
12/18/2025
How KNSA stock reacts to global recession fears - Breakout Watch & Long-Term Growth Plans Улправда
Read more →Will KNSA stock remain a Wall Street favorite - 2025 Technical Overview & Stepwise Entry and Exit Trade Signals Улправда
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$54
Analyst Picks
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 43.95% of the total shares of Kiniksa Pharmaceuticals Ltd
1.
Rubric Capital Management LP(5.2758%)
since
2025/06/30
2.
Vanguard Group Inc(4.2257%)
since
2025/06/30
3.
Baker Bros Advisors LP(3.8116%)
since
2025/06/30
4.
TANG CAPITAL MANAGEMENT LLC(3.1422%)
since
2025/06/30
5.
Fairmount Funds Management LLC(2.3922%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(1.6084%)
since
2025/07/31
7.
BRAIDWELL LP(1.4878%)
since
2025/06/30
8.
Morgan Stanley - Brokerage Accounts(1.4388%)
since
2025/06/30
9.
Millennium Management LLC(1.3763%)
since
2025/06/30
10.
Pictet Asset Manangement SA(1.3286%)
since
2025/06/30
11.
Vanguard Small Cap Index(1.2476%)
since
2025/07/31
12.
Qube Research & Technologies(1.1987%)
since
2025/06/30
13.
Point72 Asset Management, L.P.(1.145%)
since
2025/06/30
14.
FMR Inc(1.0888%)
since
2025/06/30
15.
D. E. Shaw & Co LP(1.0678%)
since
2025/06/30
16.
Arrowstreet Capital Limited Partnership(0.9924%)
since
2025/06/30
17.
BlackRock Inc(0.9485%)
since
2025/06/30
18.
Cubist Systematic Strategies, LLC(0.8872%)
since
2025/06/30
19.
Dimensional Fund Advisors, Inc.(0.8749%)
since
2025/06/30
20.
Driehaus Capital Management LLC(0.8744%)
since
2025/06/30
21.
Rice Hall James & Associates, LLC(0.8612%)
since
2025/06/30
22.
Connor Clark & Lunn Inv Mgmt Ltd(0.8416%)
since
2025/06/30
23.
Pictet-Biotech P USD(0.73%)
since
2025/05/31
24.
Vanguard Small Cap Growth Index Inv(0.7078%)
since
2025/07/31
25.
Fidelity Small Cap Growth(0.6616%)
since
2025/06/30
26.
Pictet-Global Megatrend Sel I USD(0.5638%)
since
2025/05/31
27.
Oberweis Micro-Cap(0.4118%)
since
2025/06/30
28.
Oberweis Micro-Cap Growth(0.4118%)
since
2025/06/30
29.
Heptagon Driehaus US Micro Cap Eq C$ Acc(0.3624%)
since
2025/07/31
30.
Fidelity Small Cap Growth K6(0.3032%)
since
2025/06/30
31.
Xtrackers MSCI World Swap ETF 1C(0.2266%)
since
2025/07/31
32.
Xtrackers S&P 500 Swap ETF 1C(0.1893%)
since
2025/07/31
33.
Peregrine Capital Mgt Sm-Cap Growth(0.1758%)
since
2025/06/30
34.
Allspring Small Company Gr(0.1668%)
since
2025/07/31
35.
Allspring Small Company Growth A(0.1668%)
since
2025/07/31
36.
Vanguard Strategic Equity Inv(0.162%)
since
2025/06/30
37.
DFA US Small Cap I(0.1575%)
since
2025/07/31
38.
Scout Small Cap Equity(0.1501%)
since
2024/12/31
39.
Vanguard Explorer Inv(0.1494%)
since
2025/06/30
40.
Driehaus Micro Cap Growth USD(0.1425%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.23
EPS Estimate
0.3139
EPS Difference
-0.0839
Surprise Percent
-26.7283%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.